We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EC: Most Patent Settlements Continue to Delay Generic Launches
EC: Most Patent Settlements Continue to Delay Generic Launches
A majority of patent settlements reached last year in the European Union restricted the market entry of generics, according to a European Commission report.